If a fund manager was confronted with a company trading on a PE ratio of 40 and a dividend yield of 2.5 per cent, they would likely deduct one of two things.
One explanation could be that this company has exceptionally strong growth prospects, and the high valuation reflects a likely big ramp up in earnings in the years to come.
Fisher & Paykel Healthcare fits into this camp, as one of the most expensive companies on the local market. Its PE ratio of 35 is double the average, and its dividend yield of 2.7% about half the average.
New Zealanders have this unwavering expectation that house prices only ever go up, and that owning them is a guaranteed way to getting rich.
This high valuation is acceptable because its growth prospects are very strong. Profits are up almost 80 per cent over the last three years, and earnings and dividends could rise another 80 per cent over the next three.
The second possibility is that the company has only modest growth prospects, and the market has got the valuation completely wrong, as was the case in 1999 with US technology companies.
I think I know where Auckland houses sit on this scale, and they're no Fisher & Paykel Healthcare.
New Zealanders have this unwavering expectation that house prices only every go up, and that owning them is a guaranteed way to getting rich. Maybe it's the herd mentality or the aversion to shares that's been with us since 1987, but the obsession is taking us into dangerous territory.
Not only are some very unappealing social outcomes looming, but the housing fixation is causing people to make some dangerous financial choices.
In many ways, a major correction would be a good thing for us all in the longer-term. Not only would it bring prices back to reality but it would burn a few people, teaching some valuable lessons about risk, leverage and overconfidence.
Ironically, I worry these trends are actually working in reverse and that in the eyes of authorities and policy makers, the housing market is becoming too big to fail.
Debate on this article is now closed.
Mark Lister is Head of Private Wealth Research at Craigs Investment Partners. His disclosure statement is available free of charge under his profile on www.craigsip.com. This column is general in nature and should not be regarded as specific investment advice.